REVIEW OF THE VISUAL-SYSTEM IN PARKINSONS-DISEASE

被引：20

作者：

HUNT, LA

SADUN, AA

BASSI, CJ

机构：

[1] Washington University, St. Louis

[2] Missouri and School of Optometry, University of Missouri-St. Louis, St. Louis, MO

[3] Doheny Eye Institute, University of Southern California, School of Medicine, Los Angeles, CA

[4] School of Optometry, Univrsity of Mfssouri-St. Louis, St. Louis, MO

来源：

OPTOMETRY AND VISION SCIENCE | 1995年 / 72卷 / 02期

关键词：

PARKINSONS DISEASE; VISION; PSYCHOPHYSICS; ELECTROPHYSIOLOGY; VISION AND PERFORMANCE;

D O I：

10.1097/00006324-199502000-00008

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

In an era when the prevalence of Parkinson's disease (PD) is increasing because our population is aging, eye care professionals need to become aware of the visual changes experienced by PD patients. This paper reviews the visual pathophysiology of PD and the results of the lack of dopamine on the retina and visual cortex. It also discusses the impact of PD on the oculomotor system and the visual sensory pathways with the consequent effects on reading, balance, and driving abilities of PD patients. Further research on the visual system and PD may provide improved means for early diagnostic testing as well as the possibility of vision rehabilitation for treatment of visual performance impairments.

引用

页码：92 / 99

页数：8

共 59 条

[1] Parkinson J., An essay on shaking palsy, Med Classics, 2, pp. 964-997, (1938)
[2] Marttila R.J., Rinne U.K., Epidemiology of Parkinson’s disease: An overview, J Neural Transm, 51, pp. 135-148, (1981)
[3] Diamond S.G., Markham C.H., Hoehn M.M., McDowell F.H., Muenter M.D., An examination of male-female differences in progression and mortality of Parkinson’s disease, Neurology, 40, pp. 763-766, (1990)
[4] Cote L., Crutcher M.D., The basal ganglia, Principles of Neural Science, pp. 647-659, (1991)
[5] Hoehn M.M., Yahr M.D., Parkinsonism: Onset, progression, and mortality, Neurology, 17, pp. 427-442, (1967)
[6] Birkmayer W., Hornykiewicz O., Advances in Parkinsonism: Biochemistry, Physiology, Treatment. Fifth International Symposium on Parkinson’s disease, Basel: Roche, (1976)
[7] Gilroy J., Meyer J.S., Medical Neurology, pp. 187-196, (1979)
[8] Stern J., Ward A.A., Supraspinal and drug modulation of the alpha motor system. Relation of supraspinal and drug modulation to parkinsonism, Arch Neurol, 6, pp. 404-413, (1962)
[9] Corin M.S., Elizan T.S., Bender M.B., Oculomotor function in patients with Parkinson’s disease, J Neurol Sci, 15, pp. 251-265, (1972)
[10] Kupersmith M.J., Shakin E., Siegel I.M., Lieberman A., Visual system abnormalities in patients with Parkinson’s disease, Arch Neurol, 39, pp. 284-286, (1982)

← 1 2 3 4 5 6 →